Advertisement

Sipa1 deficiency–induced bone marrow niche alterations lead to the initiation of myeloproliferative neoplasm

New research explores signal-induced proliferation-associated gene 1 (SIPA1) mutations, the role they play in initiation MPNs, and the potential to use this gene for future MPN therapies.

 Blood Advances